When people talk about the FDA approval process, the conversation usually splits in two directions. One side argues it takes too long. The other argues it exists for a reason. Both are right. The challenge isn’t choosing between speed and safety. It’s understanding that the FDA approval process is designed to manage risk in a system where the consequences of getting it wrong are significant. That makes the balance more complicated than most headlines suggest.

Everyone agrees the healthcare system needs to change. But almost no one agrees on how to change it. And even when they do? It takes forever.

Transparency sounds like a good thing. And in many cases, it is. But in healthcare policy, I’ve seen a troubling pattern: Transparency gets weaponized. Not to inform decisions. Not to improve outcomes. But to delay progress, justify inaction, or create political cover.